Literature DB >> 8541177

Use of lead adjustment formulas for QT dispersion after myocardial infarction.

J M Glancy1, C J Garratt, K L Woods, D P de Bono.   

Abstract

OBJECTIVE: To determine whether lead adjustment formulas for correcting QT dispersion measurements are appropriate in patients after myocardial infarction.
DESIGN: Retrospective analysis of QTc dispersion measurements in 461 electrocardiograms (ECGs). Data are presented as uncorrected QTc dispersion "adjusted" for a number of measurable leads and coefficient of variation of QTc intervals for ECGs in which between six and 12 leads had a QT interval that could be measured accurately. PATIENTS: Patients were drawn from the placebo arm of the second Leicester Intravenous Magnesium Intervention Trial. Some 163 patients who subsequently died and an equal number of known survivors had ECGs recorded on day 2 or 3 of acute myocardial infarction. ECGs were also available in 135 of these patients from at least 1 month postinfarct.
RESULTS: The most common lead in which a QT interval measurement was omitted was aVR (n = 176), the least common lead was V3 (n = 13). The longest QTc interval measured was most usually in lead V4 (n = 72) and the shortest in lead V1 (n = 67). As the number of measurable leads decreased there was a small, nonsignificant increase in QTc dispersion from 12 lead to eight lead ECGs (mean (SD) 100 (35.5) v 109.5 (47.9) ms). Lead adjusted QTc dispersion (QTc dispersion/square root of the number of measurable leads) showed a large, significant increase when the number of measurable leads decreased from 12 to eight (28.9 (10.3) v 38.7 (16.1) ms, P < 0.001). A similar trend was seen for coefficient of variation of QTc intervals (standard deviation of QTc intervals/mean QTc interval 64.3 (2.19) v 8.45 (3.94)%, P < 0.001).
CONCLUSIONS: Lead adjustment formulas for QT dispersion are not appropriate in patients with myocardial infarction. Large differences in lead adjusted QTc dispersion are produced, dependent on the number of measurable leads, for very small differences in QTc dispersion. It is recommended that QT dispersion is presented as unadjusted QT and QTc dispersion, stating the mean (SD) of the number of leads in which a QT interval was measured.

Entities:  

Mesh:

Year:  1995        PMID: 8541177      PMCID: PMC484130          DOI: 10.1136/hrt.74.6.676

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Reduction in QT dispersion by sotalol following myocardial infarction.

Authors:  C P Day; J M McComb; J Matthews; R W Campbell
Journal:  Eur Heart J       Date:  1991-03       Impact factor: 29.983

2.  The measurement of the Q-T interval of the electrocardiogram.

Authors:  E LEPESCHKIN; B SURAWICZ
Journal:  Circulation       Date:  1952-09       Impact factor: 29.690

3.  Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

Authors:  G Buja; M Miorelli; P Turrini; P Melacini; A Nava
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

4.  Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects.

Authors:  J Kautzner; G Yi; A J Camm; M Malik
Journal:  Pacing Clin Electrophysiol       Date:  1994-05       Impact factor: 1.976

Review 5.  QT dispersion.

Authors:  P D Higham; R W Campbell
Journal:  Br Heart J       Date:  1994-06

6.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Authors:  K L Woods; S Fletcher; C Roffe; Y Haider
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

7.  Automated measurement of QT interval dispersion from hard-copy ECGs.

Authors:  H K Bhullar; J C Fothergill; W P Goddard; D P de Bono
Journal:  J Electrocardiol       Date:  1993-10       Impact factor: 1.438

8.  QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias?

Authors:  M Pye; A C Quinn; S M Cobbe
Journal:  Br Heart J       Date:  1994-06

9.  Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes.

Authors:  N J Linker; P Colonna; C A Kekwick; J Till; A J Camm; D E Ward
Journal:  Am J Cardiol       Date:  1992-03-01       Impact factor: 2.778

10.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

View more
  3 in total

1.  Measuring QT dispersion: man versus machine.

Authors:  A Murray; N B McLaughlin; R W Campbell
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Improving the reproducibility of QT dispersion measures.

Authors:  K Lund; J S Perkiömäki; C Brohet; M Zaïdi; H Elming; C T Pedersen; H V Huikuri; H Nygaard; A K Pedersen
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-04       Impact factor: 1.468

3.  The relation of QT dispersion and localized QT difference to coronary pathology in a population with unstable coronary artery disease.

Authors:  Milos Kesek; Anders Englund; Tomas Jernberg; Bo Lagerqvist; Bertil Lindahl
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.